Jackie M Poos
Overview
Explore the profile of Jackie M Poos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Boer L, Poos J, van den Berg E, De Houwer J, Swartenbroekx T, Dopper E, et al.
Neurology
. 2025 Feb;
104(5):e213401.
PMID: 39951678
Background And Objectives: With upcoming clinical trials targeting preclinical stages of genetic frontotemporal dementia (FTD), early detection through cognitive screening is crucial. The Mini-Mental State Examination (MMSE) and Montreal Cognitive...
2.
Poos J, van den Berg E, de Boer L, Meertens-Gunput S, Dopper E, Seelaar H, et al.
Aging Dis
. 2024 Nov;
PMID: 39500348
Characterization of cognitive profiles across genetic FTD gene mutations is crucial for the identification of sensitive endpoints for clinical trials targeting specific pathologies. However, no systematic overview of the literature...
3.
de Boer L, van den Berg E, Poos J, Klop W, Giannini L, De Houwer J, et al.
Alzheimers Dement (Amst)
. 2024 Sep;
16(3):e12630.
PMID: 39229325
Introduction: We aimed to assess the knowledge of social norms in patients with behavioral variant frontotemporal dementia (bvFTD) with the Dutch version of the Social Norms Questionnaire (SNQ-NL). Methods: The...
4.
Jiskoot L, van den Berg E, Vollebergh H, de Haan R, de Boer L, Poos J, et al.
Appl Neuropsychol Adult
. 2024 Apr;
:1-7.
PMID: 38615690
Background: Cognitive reserve is a potential mechanism to cope with brain damage as a result of dementia, which can be defined by indirect proxies, including education level, leisure time activities,...
5.
Giannini L, Boers R, van der Ende E, Poos J, Jiskoot L, Boers J, et al.
Ann Clin Transl Neurol
. 2024 Mar;
11(3):744-756.
PMID: 38481040
Objective: Methylation of plasma cell-free DNA (cfDNA) has potential as a marker of brain damage in neurodegenerative diseases such as frontotemporal dementia (FTD). Here, we study methylation of cfDNA in...
6.
Bodde H, Papma J, Poos J
Int Psychogeriatr
. 2024 Feb;
36(6):444-447.
PMID: 38351545
No abstract available.
7.
Giannini L, Seelaar H, van der Ende E, Poos J, Jiskoot L, Dopper E, et al.
Neurology
. 2023 Jul;
101(10):e1069-e1082.
PMID: 37491327
Background And Objectives: Elevated serum neurofilament light chain (NfL) is used to identify carriers of genetic frontotemporal dementia (FTD) pathogenic variants approaching prodromal conversion. Yet, the magnitude and timeline of...
8.
Jiskoot L, van den Berg E, Laenen S, Poos J, Giannini L, Satoer D, et al.
J Neurol
. 2023 Jul;
270(11):5418-5435.
PMID: 37462752
Background: The semantic fluency test is one of the most widely used neuropsychological tests in dementia diagnosis. Research utilizing the qualitative, psycholinguistic information embedded in its output is currently underexplored...
9.
Jiskoot L, Russell L, Peakman G, Convery R, Greaves C, Bocchetta M, et al.
J Neurol Sci
. 2023 Feb;
446:120590.
PMID: 36812822
Objective: Sensitive cognitive markers are still needed for frontotemporal dementia (FTD). The Benson Complex Figure Test (BCFT) is an interesting candidate test, as it assesses visuospatial, visual memory, and executive...
10.
Jiskoot L, Russell L, Greaves C, van Schaik E, van den Berg E, Poos J, et al.
J Neurol
. 2023 Feb;
270(5):2674-2687.
PMID: 36811680
Most neuropsychiatric symptoms (NPS) common in frontotemporal dementia (FTD) are currently not part of the Neuropsychiatric Inventory (NPI). We piloted an FTD Module that included eight extra items to be...